Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

GSK3B polymorphisms alter transcription and splicing in Parkinson's disease.

Kwok JB, Hallupp M, Loy CT, Chan DK, Woo J, Mellick GD, Buchanan DD, Silburn PA, Halliday GM, Schofield PR.

Ann Neurol. 2005 Dec;58(6):829-39.

PMID:
16315267
2.

MAPT rs242562 and GSK3B rs334558 are associated with Parkinson's Disease in central China.

Yu L, Huang J, Zhai D, Liu L, Guo K, Long X, Xiong J, Zhang Z, Wang Y, Zhao Y, Wu P, Wang D, Lin Z, Wu J, Xiong N, Wang T.

BMC Neurosci. 2014 Apr 29;15:54. doi: 10.1186/1471-2202-15-54.

3.

Glycogen synthase kinase-3beta and tau genes interact in Alzheimer's disease.

Kwok JB, Loy CT, Hamilton G, Lau E, Hallupp M, Williams J, Owen MJ, Broe GA, Tang N, Lam L, Powell JF, Lovestone S, Schofield PR.

Ann Neurol. 2008 Oct;64(4):446-54. doi: 10.1002/ana.21476.

PMID:
18991351
4.

Role of tau kinases (CDK5R1 and GSK3B) in Parkinson's disease: a study from India.

Das G, Misra AK, Das SK, Ray K, Ray J.

Neurobiol Aging. 2012 Jul;33(7):1485.e9-15. doi: 10.1016/j.neurobiolaging.2010.10.016. Epub 2010 Dec 3.

PMID:
21130530
5.

GSK3β polymorphisms, MAPT H1 haplotype and Parkinson's disease in a Greek cohort.

Kalinderi K, Fidani L, Katsarou Z, Clarimón J, Bostantjopoulou S, Kotsis A.

Neurobiol Aging. 2011 Mar;32(3):546.e1-5. doi: 10.1016/j.neurobiolaging.2009.05.007. Epub 2009 Jul 1.

PMID:
19573950
6.

SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study.

Wider C, Vilariño-Güell C, Heckman MG, Jasinska-Myga B, Ortolaza-Soto AI, Diehl NN, Crook JE, Cobb SA, Bacon JA, Aasly JO, Gibson JM, Lynch T, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA.

Eur J Neurol. 2011 Jun;18(6):876-81. doi: 10.1111/j.1468-1331.2010.03297.x. Epub 2010 Dec 15.

PMID:
21159074
7.

Association analysis of GSK3B and MAPT polymorphisms with Alzheimer's disease in Han Chinese.

Zhang N, Yu JT, Yang Y, Yang J, Zhang W, Tan L.

Brain Res. 2011 May 19;1391:147-53. doi: 10.1016/j.brainres.2011.03.052. Epub 2011 Mar 26.

PMID:
21443865
8.

GSK3B and MAPT polymorphisms are associated with grey matter and intracranial volume in healthy individuals.

Dobson-Stone C, Polly P, Korgaonkar MS, Williams LM, Gordon E, Schofield PR, Mather K, Armstrong NJ, Wen W, Sachdev PS, Kwok JB.

PLoS One. 2013 Aug 12;8(8):e71750. doi: 10.1371/journal.pone.0071750. eCollection 2013.

9.

Tau haplotypes regulate transcription and are associated with Parkinson's disease.

Kwok JB, Teber ET, Loy C, Hallupp M, Nicholson G, Mellick GD, Buchanan DD, Silburn PA, Schofield PR.

Ann Neurol. 2004 Mar;55(3):329-34.

PMID:
14991810
10.

Association of GSK3B with Alzheimer disease and frontotemporal dementia.

Schaffer BA, Bertram L, Miller BL, Mullin K, Weintraub S, Johnson N, Bigio EH, Mesulam M, Wiedau-Pazos M, Jackson GR, Cummings JL, Cantor RM, Levey AI, Tanzi RE, Geschwind DH.

Arch Neurol. 2008 Oct;65(10):1368-74. doi: 10.1001/archneur.65.10.1368.

11.

Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson's disease.

Refenes N, Bolbrinker J, Tagaris G, Orlacchio A, Drakoulis N, Kreutz R.

BMC Neurol. 2009 Jun 28;9:26. doi: 10.1186/1471-2377-9-26.

12.

Role of ethnicity on the association of MAPT H1 haplotypes and subhaplotypes in Parkinson's disease.

Winkler S, König IR, Lohmann-Hedrich K, Vieregge P, Kostic V, Klein C.

Eur J Hum Genet. 2007 Nov;15(11):1163-8. Epub 2007 Jul 18.

13.

Haplotype-specific MAPT exon 3 expression regulated by common intronic polymorphisms associated with Parkinsonian disorders.

Lai MC, Bechy AL, Denk F, Collins E, Gavriliouk M, Zaugg JB, Ryan BJ, Wade-Martins R, Caffrey TM.

Mol Neurodegener. 2017 Oct 30;12(1):79. doi: 10.1186/s13024-017-0224-6.

14.

Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease.

Zabetian CP, Hutter CM, Factor SA, Nutt JG, Higgins DS, Griffith A, Roberts JW, Leis BC, Kay DM, Yearout D, Montimurro JS, Edwards KL, Samii A, Payami H.

Ann Neurol. 2007 Aug;62(2):137-44.

15.

The association between glycogen synthase kinase 3 beta polymorphisms and Parkinson's disease susceptibility: a meta-analysis.

Yuan Y, Tong Q, Zhou X, Zhang R, Qi Z, Zhang K.

Gene. 2013 Jul 25;524(2):133-8. doi: 10.1016/j.gene.2013.04.045. Epub 2013 Apr 26.

PMID:
23628795
16.

Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease.

Goris A, Williams-Gray CH, Clark GR, Foltynie T, Lewis SJ, Brown J, Ban M, Spillantini MG, Compston A, Burn DJ, Chinnery PF, Barker RA, Sawcer SJ.

Ann Neurol. 2007 Aug;62(2):145-53.

PMID:
17683088
17.

H1/H2 MAPT haplotype and Parkinson's disease in Mexican mestizo population.

Miranda-Morales EG, Sandoval-Carrillo A, Castellanos-Juárez FX, Méndez-Hernández EM, La Llave-León O, Quiñones-Canales G, Ruano-Calderón LA, Arias-Carrión O, Salas-Pacheco JM.

Neurosci Lett. 2019 Jan 18;690:210-213. doi: 10.1016/j.neulet.2018.10.029. Epub 2018 Oct 16.

PMID:
30339920
18.

Association of the MAPT locus with Parkinson's disease.

Wider C, Vilariño-Güell C, Jasinska-Myga B, Heckman MG, Soto-Ortolaza AI, Cobb SA, Aasly JO, Gibson JM, Lynch T, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA.

Eur J Neurol. 2010 Mar;17(3):483-6. doi: 10.1111/j.1468-1331.2009.02847.x. Epub 2009 Nov 12.

19.

Correlation of tau gene polymorphism with age at onset of Parkinson's disease.

Kobayashi H, Ujike H, Hasegawa J, Yamamoto M, Kanzaki A, Sora I.

Neurosci Lett. 2006 Sep 25;405(3):202-6. Epub 2006 Jul 28.

PMID:
16876320
20.

The tau gene haplotype h1 confers a susceptibility to Parkinson's disease.

Zhang J, Song Y, Chen H, Fan D.

Eur Neurol. 2005;53(1):15-21. Epub 2004 Dec 27.

PMID:
15627775

Supplemental Content

Support Center